A comparative study on the efficacy of coenzyme Q10 and amitriptyline in the prophylactic treatment of migraine headaches in children: A randomized controlled trial

Document Type : Original Article

Authors
Omid Yaghini 1
Neda Hoseini 2
Mohammad Reza Ghazavi 1
Vahid Mansouri 1
Jafar Nasiri 1
Toktam Moosavian 2
Mohammad Mehdi Salehi 2
1 Department of Medicine, Isfahan University of Medical Sciences; Child growth and Development Research Center, School of medicine, Isfahan University of Medical Sciences, Isfahan, Iran
2 Department of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
Abstract
Background: Migraine, one of the most common headaches in children, has a significant impact on children and their family's quality of life (QoL). There are two approaches for controlling migraine headaches preventative and controlling acute attacks. Several drugs have been used for this purpose, and tricyclic antidepressants were at the top. Amitriptyline has shown not only a desirable effect on controlling the headaches but also some adverse side effects. Recently, finding effective drugs with fewer side effects, become more critical. Among them, nutraceuticals were one of the promising ones. Materials and Methods: In this randomized clinical trial on 72 patients aged 5–15 years old with diagnosis of migraine based on the International Headache Society criteria, we compare the effectiveness of coenzyme Qten on frequency, duration, and severity of childhood migraine. For comparing the QoL, we used the International PedMIDAS questionnaire. Results: Coenzyme Qten showed good therapeutic effects in children, especially in long-term use; however, amitriptyline showed more rapid response. After 3 months of treatment, clinical outcomes in the two groups did not significantly differ from each other. Similarly, Children's QoL increased in the same way. There are more reported side effects in children using amitriptyline compared to coenzyme Qten. Conclusions: According to results, Co-enzyme Q10, with fewer side effects and comparable therapeutic effects, especially in the long term, could be a good drug for prophylactic treatment of migraine headaches.

Keywords

1.
Ashrafi MR, Salehi S, Malamiri RA, Heidari M, Hosseini SA, Samiei M, et al. Efficacy and safety of cinnarizine in the prophylaxis of migraine in children: A double-blind placebo-controlled randomized trial. Pediatr Neurol 2014;51:503-8.  Back to cited text no. 1
    
2.
Green A, Kabbouche M, Kacperski J, Hershey A, O'Brien H. Managing migraine headaches in children and adolescents. Expert Rev Clin Pharmacol 2016;9:477-82.  Back to cited text no. 2
    
3.
Kabbouche MA, Kacperski J, O'Brien HL, Powers SW, Hershey AD. Headache in Children and Adolescents. In: Swaiman KF, Ashwal S, Ferriero DM, Schor NF, Finkel RS, Gropman AL, et al., editors. Swaiman's Pediatric Neurology. Edinburgh: Elsevier Saunders: Elsevier; 2017. p. 647-55.  Back to cited text no. 3
    
4.
Kacperski J, Kabbouche MA, O'Brien HL, Weberding JL. The optimal management of headaches in children and adolescents. Ther Adv Neurol Disord 2016;9:53-68.  Back to cited text no. 4
    
5.
Kliegman RM, Stanton B, Geme JW, Schor NF, Behrman RE. Nelson Textbook of Pediatrics. Philadelphia, PA: Elsevier; 2016.  Back to cited text no. 5
    
6.
Piña-Garza JE, Fenichel GM. Fenichel's Clinical Pediatric Neurology: A Signs and Symptoms Approach.Philadelphia, PA: Elsevier.: Elsevier Saunders; 2013.  Back to cited text no. 6
    
7.
Sabri MR, Dehghan B, Yaghini O, Nasiri J, Mansourian M, Khalifehsoltani S. Endothelial dysfunction state in migraine headache and neutrally mediated syncope in children and young adults. J Res Med Sci 2015;20:771-6.  Back to cited text no. 7
[PUBMED]  [Full text]  
8.
Teleanu RI, Vladacenco O, Teleanu DM, Epure DA. Treatment of pediatric migraine: A review. Maedica (Bucur) 2016;11:136-43.  Back to cited text no. 8
    
9.
Yaghini O, Shahkarami SM, Mahmoudian T, Hashemi EH. Comprehensive assessment of the relative frequency of sleep disorders in migraine and non migraine in 6 to 14-year-old children. Iran J Child Neurol 2011;4:33-6.  Back to cited text no. 9
    
10.
Schwedt TJ. Preventive Therapy of Migraine. Continuum (Minneap Minn) 2018;24(4, Headache):1052-65.  Back to cited text no. 10
    
11.
Orr SL, Venkateswaran S. Nutraceuticals in the prophylaxis of pediatric migraine: Evidence-based review and recommendations. Cephalalgia 2014;34:568-83.  Back to cited text no. 11
    
12.
Orr SL. The evidence for the role of nutraceuticals in the management of pediatric migraine: A review. Curr Pain Headache Rep 2018;22:37.  Back to cited text no. 12
    
13.
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018;38:1-211.  Back to cited text no. 13
    
14.
Topcu Y, Hiz Kurul S, Bayram E, Sozmen K, Yis U. The paediatric migraine disability assessment score is a useful tool for evaluating prophylactic migraine treatment. Acta Paediatr 2014;103:e484-9.  Back to cited text no. 14
    
15.
Sadeghian H, Motiei-Langroudi R. Comparison of levetiracetam and sodium valproate in migraine prophylaxis: A randomized placebo-controlled study. Ann Indian Acad Neurol 2015;18:45-8.  Back to cited text no. 15
[PUBMED]  [Full text]  
16.
Sándor PS, Di Clemente L, Coppola G, Saenger U, Fumal A, Magis D, et al. Efficacy of coenzyme Q10 in migraine prophylaxis: A randomized controlled trial. Neurology 2005;64:713-5.  Back to cited text no. 16
    
17.
Slater SK, Nelson TD, Kabbouche MA, LeCates SL, Horn P, Segers A, et al. A randomized, double-blinded, placebo-controlled, crossover, add-on study of CoEnzyme Q10 in the prevention of pediatric and adolescent migraine. Cephalalgia 2011;31:897-905.  Back to cited text no. 17
    
18.
Dalla Volta G, Carli D, Zavarise P, Ngonga G, Vollaro S. P026. Pilot study on the use of coenzyme Q10 in a group of patients with episodic migraine without aura. J Headache Pain 2015;16:A186.  Back to cited text no. 18
    
19.
Tonekaboni SH, Ghazavi A, Fayyazi A, Khajeh A, Taghdiri MM, Abdollah Gorji F, et al. Prophylaxis of childhood migraine: Topiramate versus propranolol. Iran J Child Neurol 2013;7:9-14.  Back to cited text no. 19
    
20.
Hajihashemi P, Askari G, Khorvash F, Reza Maracy M, Nourian M. The effects of concurrent Coenzyme Q10, L-carnitine supplementation in migraine prophylaxis: A randomized, placebo-controlled, double-blind trial. Cephalalgia 2019;39:648-54.  Back to cited text no. 20
    
21.
Dahri M, Tarighat-Esfanjani A, Asghari-Jafarabadi M, Hashemilar M. Oral coenzyme Q10 supplementation in patients with migraine: Effects on clinical features and inflammatory markers. Nutr Neurosci 2019;22:607-15.  Back to cited text no. 21
    
22.
Guilbot A, Bangratz M, Ait Abdellah S, Lucas C. A combination of coenzyme Q10, feverfew and magnesium for migraine prophylaxis: A prospective observational study. BMC Complement Altern Med 2017;17:433.  Back to cited text no. 22
    
23.
Hershey AD, Powers SW, Vockell AL, Lecates SL, Ellinor PL, Segers A, et al. Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine. Headache 2007;47:73-80.  Back to cited text no. 23
    
24.
Fallah R, Fazelishoroki F, Sekhavat L. A randomized clinical trial comparing the efficacy of melatonin and amitriptyline in migraine prophylaxis of children. Iran J Child Neurol 2018;12:47-54.  Back to cited text no. 24
Advanced Biomedical Research
Volume 2022, May
May 2022
Pages 1-6